SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sayarlioglu, M
Right arrow Articles by Konice, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sayarlioglu, M
Right arrow Articles by Konice, M
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Lupus
*Tuberculosis
Hazardous Substances DB
*PREDNISOLONE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization

M Sayarlioglu

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey, sayarli{at}hotmail.com

M Inanc

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

S Kamali

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

A Cefle

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

O Karaman

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

A Gul

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

L Ocal

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

O Aral

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

M Konice

Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

The objectivewas to investigatethe frequencyand characteristicsof tuberculosis(TB) in patients with systemic lupus erythematosus (SLE). We reviewed the charts of 556 patients with SLE who were followed up between 1978 and 2001 in our lupus clinic. Patientswho developedTB after the diagnosis of SLE were identified (SLE/TB). Ninety-six consecutive patients with SLE who did not develop TB during the follow-up were evaluated as a control group (SLE/TB-). Clinical, laboratory and management characteristics of these two groups of patients were recorded according to a predefined protocol, and compared. Of the 556 patients evaluated, 20 patients (3.6%) with TB were identified. Nine of the 20 patients (45%) had extrapulmonary TB (vertebral involvement in three patients, meningeal in two, and joint and soft tissue in four). Arthritis and renal involvement were significantly high in the SLE/TB group (P 0.045, P 0.009, respectively). The mean daily dose of prednisolonebefore the diagnosis of TB and the cumulative dose of prednisolonewere significantly higher in the SLE/TB group compared to the SLE/TB- group (27 + 22 g versus 16 + 16 g, 24 + 45 mg versus 11 + 8.5 mg, respectively). In conclusion, we found an increased frequency of TB infection and a high prevalence of extrapulmonary TB in a large cohort of SLE patients. The mean daily dose of prednisolonebefore the diagnosisof TB and the cumulativedose of prednisolone, which possibly related to disease severity, were important determinants for the increased risk of TB in these patients with SLE.

Key Words: systemic lupus erythematosus • tuberculosis

Lupus, Vol. 13, No. 4, 274-278 (2004)
DOI: 10.1191/0961203303lu529xx


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
QJMHome page
B. Hodkinson, E. Musenge, and M. Tikly
Osteoarticular tuberculosis in patients with systemic lupus erythematosus
QJM, May 1, 2009; 102(5): 321 - 328.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. Wadee, M. Tikly, and M. Hopley
Causes and predictors of death in South Africans with systemic lupus erythematosus
Rheumatology, September 1, 2007; 46(9): 1487 - 1491.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
J-G Erdozain, G Ruiz-Irastorza, M-V Egurbide, A Martinez-Berriotxoa, and C Aguirre
High risk of tuberculosis in systemic lupus erythematosus?
Lupus, April 1, 2006; 15(4): 232 - 235.
[Abstract] [PDF]



Advertisement